financetom
Business
financetom
/
Business
/
Biohaven meets main trial goal for rare genetic disease treatment
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Biohaven meets main trial goal for rare genetic disease treatment
Mar 11, 2026 7:18 AM

Sept 23 (Reuters) - Biohaven ( BHVN ) said on Monday it

had met the main goal in a study evaluating its treatment in

patients with an inherited disease that mainly affects the

brain.

(Reporting by Christy Santhosh; Editing by Anil D'Silva)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US FDA approves gradual dosing for Lilly Alzheimer's drug
US FDA approves gradual dosing for Lilly Alzheimer's drug
Jul 9, 2025
July 9 (Reuters) - The U.S. Food and Drug Administration approved changing the prescribing information for Eli Lilly's ( LLY ) Alzheimer's drug Kisunla to allow more gradual dosing to lower the risk of a potentially dangerous type of brain swelling, the company said on Wednesday. Kisunla, given as a monthly infusion, is part of a class of drugs designed...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Market Chatter: Starbucks China Draw Bids Valuing Business Up to $10 Billion
Market Chatter: Starbucks China Draw Bids Valuing Business Up to $10 Billion
Jul 9, 2025
06:47 AM EDT, 07/09/2025 (MT Newswires) -- Starbucks ( SBUX ) China has attracted offers from nearly 30 private equity firms with valuations ranging from $5 billion to $10 billion, CNBC reported Wednesday, citing people familiar with the matter. The coffee chain is evaluating proposals and may shortlist bidders within two months, the report said. Starbucks ( SBUX ) could...
China Automotive New Electro-Hydraulic Steering System Enters Mass Production
China Automotive New Electro-Hydraulic Steering System Enters Mass Production
Jul 9, 2025
06:49 AM EDT, 07/09/2025 (MT Newswires) -- China Automotive Systems ( CAAS ) said Wednesday its L2+ standard electro-hydraulic steering system entered mass production in China. The power steering system is used in heavy-duty vehicles that utilizes both hydraulic power and electronic controls. The company said the system is expected to lower operational costs by about 36,000 Chinese renminbi ($5,014.80)...
Copyright 2023-2026 - www.financetom.com All Rights Reserved